UBS Group AG is the biggest individual institutional holder of Cyclacel Pharmaceuticals Inc (CYCCP), owning a total of 677 shares. Combined, the top 1 institutional holders of CYCCP own 0.00% of the company with a total of 677 shares.
In the latest ownership report, the top 1 institutional holders have increased their combined ownership of CYCCP by 677 shares, a 50.00% increase from the quarter prior.
Institution Ownership Chart
|Owner||Percent Owned||Percent Change||Shares Owned||Share Change||Date Reported|
|UBS Group AG||0.000%||0.000%||677||677||2021-12-31|